Detalles de la búsqueda
1.
Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
Ann Surg Oncol
; 30(4): 2048-2056, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36566258
2.
Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases.
Br J Surg
; 110(11): 1502-1510, 2023 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37467389
3.
The Impact of Low Skeletal Muscle Mass on Short- and Long-Term Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Ann Surg Oncol
; 29(9): 5830-5841, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35650370
4.
Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma.
Ann Surg Oncol
; 29(11): 6566-6576, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35513588
5.
Predictive Ability of C-Reactive Protein in Detecting Short-Term Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Retrospective Cross-Sectional Study.
Ann Surg Oncol
; 28(1): 233-243, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32524458
6.
The Accuracy of the Surgical Peritoneal Cancer Index in Patients with Peritoneal Metastases of Colorectal Cancer.
Dig Surg
; 38(3): 205-211, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33657551
7.
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)
BMC Cancer
; 19(1): 390, 2019 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31023318
8.
ASO Visual Abstract: Treatment and Survival Outcomes of Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
Ann Surg Oncol
; 30(4): 2057, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36719571
9.
Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution.
Ann Surg Oncol
; 24(4): 990-997, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27896510
10.
Development of a prediction model for recurrence in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Eur J Surg Oncol
; 50(6): 108294, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583215
11.
Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial.
BMJ Open
; 14(1): e077667, 2024 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38238055
12.
Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial.
J Clin Oncol
; 42(2): 140-145, 2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37922442
13.
Impact of centralization of care for malignant peritoneal mesothelioma: A historical cohort study from the Dutch mesothelioma expert centers.
Eur J Surg Oncol
; 49(3): 611-618, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36610896
14.
Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial.
J Immunother Cancer
; 11(8)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37536940
15.
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies.
Drugs
; 83(2): 159-180, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36633826
16.
Intraperitoneal paclitaxel for patients with primary malignant peritoneal mesothelioma: a phase I/II dose escalation and safety study-INTERACT MESO.
BMJ Open
; 12(6): e062907, 2022 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35732399
17.
Monitoring of mitochondrial oxygenation during perioperative blood loss.
BMJ Case Rep
; 14(1)2021 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33468633
18.
Nasogastric- vs. percutaneous gastrostomy tube for prophylactic gastric decompression after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Pleura Peritoneum
; 6(2): 57-65, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34179339
19.
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial.
JAMA Surg
; 156(8): 710-720, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34009291
20.
A population-based study on the prognostic impact of primary tumor sidedness in patients with peritoneal metastases from colon cancer.
Cancer Med
; 9(16): 5851-5859, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32614506